J&J Settles Talcum Powder Lawsuits From States for $700 Million

2024-06-13

专利侵权

THURSDAY, June 13, 2024 -- Johnson & Johnson will pay $700 million to settle claims from 42 states and the District of Columbia that the company continued to market its talcum powder products even as evidence tied them to a heightened risk for cancer.

J&J did not admit to any wrongdoing in settling with the states, which were led by Florida, Texas and North Carolina.

“We have reached a landmark settlement with Johnson & Johnson ensuring that the company will abide by the law and take effective steps to protect consumers from potentially hazardous ingredients,” Texas Attorney General Ken Paxton said in a statement released Tuesday. “I’m proud to lead this coalition of 43 attorneys general to stand up for consumers’ health and truth in marketing.”

As part of the settlement, which still needs judicial approval, the company has stopped making, promoting and selling all of its products that contain talcum powder. That includes Johnson's Baby Powder and Johnson & Johnson's Shower to Shower. J&J will make four settlement payments, starting at the end of July, according to the settlement.

“This is a major advancement for consumer product safety, as Johnson & Johnson has stopped the manufacturing and marketing of products containing talc powder -- which may be linked to serious health issues, including cancer,” Florida Attorney General Ashley Moody said in a statement.

"Companies cannot deceive people about the safety of the products they are selling,” North Carolina Attorney General Josh Stein said in a statement. “People need to have accurate information so they can buy the right products for their health.”

J&J stopped selling talcum-based baby powder globally last year, switching to corn starch as the main ingredient. The company still faces tens of thousands of talc lawsuits, and a class action lawsuit accuses company of hiding the dangers of talcum powder from shareholders, Reuters reported.

As of March 31, more than 61,000 were still suing J&J over talcum powder products. Most are women with ovarian cancer, while a smaller number had mesothelioma, a type of cancer linked to asbestos exposure, Reuters reported.

On May 1, J&J proposed a $6.48 billion settlement to resolve most of the litigation through a third bankruptcy filing. It has set aside an $11 billion reserve to cover all talc liabilities, Reuters reported.

“The company continues to pursue several paths to achieve a comprehensive and final resolution of the talc litigation,” Erik Haas, J&J's worldwide vice president of litigation, said in a statement.

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构